Dr Reddy's aims to launch generic obesity drug at 60% discount
Dr Reddy's aims to launch generic obesity drug at 60% discount is drawing significant interest across the industry.
Indian drugmaker Dr Reddy's laboratories aims to launch a generic version of Novo Nordisk's blockbuster weight loss drug Wegovy, subject to approval, at a price about 60% lower than the branded version, co-chairman and managing director GV Prasad told Reuters on Tuesday.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- EPFO Likely To Maintain 8.25% Interest-What Market Weakness Means for Subscribers
- RIL smartly deploying cash war chest to ride AI boom; analysts remain bullish
- 4 products Apple may launch soon: iPhone 17e, iPad with A18 chip and more
- Saiyami Kher Flags Mumbai’s Air Quality Crisis, Says 'Took Me Back To Pandemic...'
Source: Original →